The United States is facing another surge in new COVID-19 cases in some states, led by Michigan, but the White House has rejected Gov. Gretchen Whitmer’s request for a corresponding increase in vaccines for her state, even as daily vaccinations they hit a record high of more than 4.6 million over the weekend. Michigan has been reporting cases at a much higher rate than any other state, with the state registering nine of the top 10 metropolitan areas with the highest case rates in the United States, according to a New York Times tracker.
New York Times, CDC
The United States leads the world by far in the number of people fully vaccinated, with more than five times the number of India ranking second, JHU data shows. While Whitmer praised Biden’s response from the White House to the COVID-19 crisis, he disagreed with the decision to stick with the vaccination plan. “When there’s a sudden spike, we think it’s important that … we rush to meet that need, because what’s happening in Michigan today could be what’s happening in other states tomorrow,” Whitmer said. “So it’s up to everyone to recognize, we can smash where we are seeing hot spots. It’s best for everyone. “Former Food and Drug Administration Commissioner Scott Gottlieb added on” Face the Nation “that Whitmer’s request for more vaccines was made weeks ago, saying the White House‘s position is a mistake. “I think we should have done it weeks ago,” Gottlieb said. “It’s never too late to do it.” The daily average of new cases in Michigan was 7,377 as of April 11, 60% higher than the average for two weeks, while average daily deaths rose 115% to 43 and hospitalizations increased 112% to 3,665, New York Times data shows. The only metropolitan area in the nation’s top 10 where the outbreak is the worst That is not in Michigan is in Illinois, where the average daily rate of new cases increased 45% in the last two weeks. In total, 28 states have seen an upward trend in case rates last week, compared to 21 statuses from the previous week, as s data provided by Johns Hopkins University. On Sunday, there were at least 48,147 new cases of COVID-19 in the United States, 296 deaths and 43,706 people hospitalized, according to data from the New York Times, although those figures may be underestimated due to the reduction of staff in the hospitals. weekends. There has been an average of 69,632 new cases per day in the last week, 11% more than the average of two weeks ago. That brings the total number of cases in the United States to 31,202,818 as of noon Monday and the death toll to 562,080, according to JHU data. Total US cases represent 22.9% of the world total and the death toll is 19.1% of the world total. In other news: • Regeneron Pharmaceuticals Inc. REGN, -0.59% on Monday shared additional positive clinical data from two studies on its COVID-19 monoclonal antibody cocktail. A late-stage trial found that subcutaneous administration of REGEN-VOC in recently infected asymptomatic patients reduced the overall risk of progressing to symptomatic infection by 31%. “These data pave the way for REGEN-COV to be used before patients become symptomatic, with more convenient subcutaneous administration,” said Dr. Katharine Bar, one of the researchers on the study, in a news release. The treatment, REGEN-COV, is currently licensed as intravenous therapy only. • CVS Health Corp. CVS, + 0.89% said Monday they will add COVID-19 vaccine locations to eligible patients in four states beginning April 14: Nebraska, Maine, Arkansas and Iowa. Appointments will be available on April 13 of April. Starting April 14, the retail pharmacy will administer vaccines at more than 6,000 locations in 49 states, Puerto Rico and Washington DC, with 70% of the US population within five miles of a location. CVS, which has the capacity for 25 million vaccines per month, says the pace of vaccines should increase as supply increases. • Walgreens, the retail pharmacy division of Walgreens Boots Alliance Inc. WBA, + 0.95%, said Monday that nearly 60,000 immunizers in more than 7,000 of its more than 9,000 retail locations, in 49 states, Washington, DC and Puerto Rico, They are administering Vaccines for COVID-19. The company said it has administered more than 11 million vaccines. • Eli Lilly & Co. LLY, -1.06% said the US government modified the purchase agreements for their COVID-19 antibody therapies. The deal for bamlanivimab, which was Lilly’s first antibody treatment to receive emergency clearance, now includes etesevimab. Using a combination of the two antibody therapies is more effective against some of the new virus variants that have emerged. Lilly said the new agreement terminates the original purchase agreement for bamlanivimab and, in effect, cancels the roughly 350,000 doses of bamlanivimab that were scheduled for delivery in March. • China’s top disease control official admitted that the country’s coronavirus vaccines have low effectiveness and is considering mixing them to try to increase protection, as reported by the Associated Press. Chinese vaccines “do not have very high protection rates,” said the director of the China Centers for Disease Control, Gao Fu, at a conference on Saturday in the southwestern city of Chengdu. • US Secretary of State Antony Blinken criticized China for its lack of transparency in the early stages of the coronavirus pandemic. “I think China knows that in the early stages of COVID, it did not do what it had to do, which was, in real time, give access to international experts, in real time, to share information, in real time. It’s time for real transparency, ”Blinken said in an interview with NBC News’s“ Meet the Press ”that aired Sunday. Latest Counts The global count of coronavirus-borne diseases rose to 136.2 million on Monday, while the death toll rose to 2,938,804. More than 77.5 million people have recovered from COVID. Brazil ranks second worldwide in cases with 13.53 million and also second with a death toll of 353,137. India ranks a close third in the world in cases with 13.48 million and fourth in deaths with 170,179. Mexico ranks third for deaths with 209,338 and 14th highest for cases with 2.28 million. The UK has 4.38 million cases and 127,331 deaths, the highest in Europe and the fifth highest in the world. China, where the virus was first discovered late last year, has had 102,069 confirmed cases and 4,843 deaths, according to its official figures.